NERV - Minerva Neurosciences, Inc

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.42 0.09 (3.72%)	---	---	---	0.0 (0.0%)	0.04 (1.62%)	0.01 (0.4%)	0.01 (0.4%)

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.43
Diluted EPS:: -0.43
Basic P/E:: -5.8372
Diluted P/E:: -5.8372
RSI(14) 1m:: 100.0
VWAP:: 2.51
RVol:: 0.146

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.56 -0.03 (-1.16%)	Oct 15 10:22
1m	Price decrease 1m	2.57 -0.05 (-2.04%)	Oct 15 10:08
60m	Price increase 60m	2.66 +0.14 (+5.56%)	Oct 15 10:04
1m	Price increase 1m	2.62 +0.03 (+1.31%)	Oct 15 10:02
10m	Price increase 10m	2.62 +0.1 (+3.77%)	Oct 15 10:02